NP Life Sciences Health Industry Group Inc. Balance Sheet
ACAT|5 years of annual SEC 10-K data (FY2019-FY2023)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
NP Life Sciences Health Industry Group Inc. had $76,864 in total assets and $16,381 in shareholders' equity as of FY2023.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | $70.6K | $121.9K | $28.0K | $118.6K | $242.9K |
| Total Assets | $76.9K | $127.8K | $38.4K | $118.6K | $250.1K |
| Current Liabilities | $38.1K | - | - | - | - |
| Shareholders' Equity | $16.4K | $19.3K | $38.2K | $103.8K | $234.9K |